Activity of α7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes

This publication has 10 references indexed in Scilit:

• Comparative pharmacology of rat and human α7 nAChR conducted with net charge analysis
  British Journal of Pharmacology, 2002
• Recent Progress in the Development of Subtype Selective Nicotinic Acetylcholine Receptor Ligands
  Current Drug Targets-CNS & Neurological Disorders, 2002
• The 5-HT 3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist
  Bioorganic & Medicinal Chemistry Letters, 2001
• (−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor
  Journal of Medicinal Chemistry, 2000
• The brain α7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)
  Behavioural Brain Research, 2000
• Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors
  Neurochemistry International, 2000
• Pharmacological characterization of a rat 5‐hydroxytryptamine type₃ receptor subunit (r5‐HT_3A(b)) expressed in Xenopus laevis oocytes
  British Journal of Pharmacology, 1998
• Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes
  Neuroscience Letters, 1998
• Nicotinic acetylcholine receptors in health and disease
  Molecular Neurobiology, 1997
• An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture
  British Journal of Pharmacology, 1993